| MVCJX | VEVYX | MVCJX / VEVYX | |
| Total Expense Ratio | 0.74 | 0.66 | 112% |
| Annual Report Gross Expense Ratio | 0.75 | 0.66 | 114% |
| Fund Existence | 21 years | 13 years | - |
| Gain YTD | 4.822 | 6.775 | 71% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.1B | 16.2B | 106% |
| Annual Yield % from dividends | 1.42 | 0.89 | 160% |
| Returns for 1 year | 2.22 | 2.79 | 80% |
| Returns for 3 years | 12.09 | 3.61 | 335% |
| Returns for 5 years | 27.39 | 20.54 | 133% |
| Returns for 10 years | 108.05 | 88.67 | 122% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BGLD | 18.00 | 0.25 | +1.41% |
| FT Vest Gold Strategy Qt Buffer ETF | |||
| PBE | 82.76 | 0.02 | +0.02% |
| Invesco Biotechnology & Genome ETF | |||
| KLMT | 31.77 | N/A | N/A |
| Invesco MSCI Global Climate 500 ETF | |||
| STXI | 32.76 | -0.05 | -0.17% |
| Strive International Developed Mkts ETF | |||
| ARKG | 30.32 | -0.30 | -0.98% |
| ARK Genomic Revolution ETF | |||